FPWR funds often help investigators develop a new line of research, obtaining the preliminary results needed to compete for larger, multi-year grants from the NIH and other organizations. Many of our researchers have been awarded these larger grants as a result of FPWR’s seed investment and support.
Investigator: James Hougland, PhD
FPWR Grant: Development and validation of ghrelin O-acyltransferase inhibitors for treating hyperphagia in Prader-Willi syndrome
American Diabetes Association: Targeting ghrelin acylation for control of glucose homeostasis ($414,000).